You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to ...
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Supergut is setting sights on bold retail expansion with the help of fresh capital and new executive leadership with a track ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...
GLP-1 medications have become a popular tool for weight loss and metabolic health, but with their rise in popularity, ...
A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.
Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...
Gut health brand Supergut has secured new capital from Full Frame Growth Partners, and brought in former CEO of Vital Proteins as CEO.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results